Pathophysiological role of calcium channels and transporters in the multiple myeloma

Cell Commun Signal. 2021 Sep 27;19(1):99. doi: 10.1186/s12964-021-00781-4.

Abstract

Multiple myeloma (MM) is a common malignant tumor of plasma cells. Despite several treatment approaches in the past two decades, MM remains an aggressive and incurable disease in dire need of new treatment strategies. Approximately 70-80% of patients with MM have myeloma bone disease (MBD), often accompanied by pathological fractures and hypercalcemia, which seriously affect the prognosis of the patients. Calcium channels and transporters can mediate Ca2+ balance inside and outside of the membrane, indicating that they may be closely related to the prognosis of MM. Therefore, this review focuses on the roles of some critical calcium channels and transporters in MM prognosis, which located in the plasma membrane, endoplasmic reticulum and mitochondria. The goal of this review is to facilitate the identification of new targets for the treatment and prognosis of MM. Video Abstract.

Keywords: Mitochondrial Ca2+ transporters; Myeloma bone disease; Plasma membrane Ca2+ transporters; Prognosis; Store-operated Ca2+ entry.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Calcium / metabolism
  • Calcium Channels / genetics*
  • Calcium Signaling / genetics*
  • Endoplasmic Reticulum / genetics
  • Humans
  • Mitochondria / genetics
  • Molecular Targeted Therapy*
  • Multiple Myeloma / genetics*
  • Multiple Myeloma / pathology
  • RNA, Small Interfering / therapeutic use

Substances

  • Calcium Channels
  • RNA, Small Interfering
  • Calcium